152 related articles for article (PubMed ID: 32905135)
1. Use of skimmed breast milk for an infant with a long-chain fatty acid oxidation disorder: A novel therapeutic intervention.
Kritzer A; Tarrant S; Sussman-Karten K; Barbas K
JIMD Rep; 2020 Sep; 55(1):44-50. PubMed ID: 32905135
[TBL] [Abstract][Full Text] [Related]
2. Triheptanoin: A Rescue Therapy for Cardiogenic Shock in Carnitine-acylcarnitine Translocase Deficiency.
Mahapatra S; Ananth A; Baugh N; Damian M; Enns GM
JIMD Rep; 2018; 39():19-23. PubMed ID: 28689308
[TBL] [Abstract][Full Text] [Related]
3. Dietary treatment of congenital chylothorax with skimmed breast milk.
Höck M; Höller A; Hammerl M; Wechselberger K; Krösslhuber J; Kiechl-Kohlendorfer U; Scholl-Bürgi S; Karall D
Ital J Pediatr; 2021 Aug; 47(1):175. PubMed ID: 34446079
[TBL] [Abstract][Full Text] [Related]
4. Tutorial: Triheptanoin and Nutrition Management for Treatment of Long-Chain Fatty Acid Oxidation Disorders.
Norris MK; Scott AI; Sullivan S; Chang IJ; Lam C; Sun A; Hahn S; Thies JM; Gunnarson M; McKean KN; Merritt JL
JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):230-238. PubMed ID: 33085788
[TBL] [Abstract][Full Text] [Related]
5. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E
Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311
[TBL] [Abstract][Full Text] [Related]
6. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
Yamada K; Taketani T
J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918
[TBL] [Abstract][Full Text] [Related]
7. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
Rubio-Gozalbo ME; Bakker JA; Waterham HR; Wanders RJ
Mol Aspects Med; 2004; 25(5-6):521-32. PubMed ID: 15363639
[TBL] [Abstract][Full Text] [Related]
8. A case report of necrotizing enterocolitis in a moderately preterm neonate with LCHADD-A call to focus on the basics while utilizing advanced new therapies.
Metzler M; Burns W; Mitchell C; Napolitano S; Chaudhari BP
Front Pediatr; 2023; 11():1081802. PubMed ID: 36861082
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes in a series of 18 patients with long chain fatty acids oxidation disorders treated with triheptanoin for a median duration of 22 months.
Guffon N; Mochel F; Schiff M; De Lonlay P; Douillard C; Vianey-Saban C
Mol Genet Metab; 2021 Apr; 132(4):227-233. PubMed ID: 33610471
[TBL] [Abstract][Full Text] [Related]
10. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.
Chalmers RA; Stanley CA; English N; Wigglesworth JS
J Pediatr; 1997 Aug; 131(2):220-5. PubMed ID: 9290607
[TBL] [Abstract][Full Text] [Related]
12. Skimmed breast milk for treatment of hypertriglyceridemia in an infant with congenital nephrotic syndrome.
Dahl AR; Armellino AL; Tran CL; Tebben PJ
Nutr Clin Pract; 2022 Apr; 37(2):383-387. PubMed ID: 34486165
[TBL] [Abstract][Full Text] [Related]
13. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response.
Vatanavicharn N; Yamada K; Aoyama Y; Fukao T; Densupsoontorn N; Jirapinyo P; Sathienkijkanchai A; Yamaguchi S; Wasant P
Brain Dev; 2015 Aug; 37(7):698-703. PubMed ID: 25459972
[TBL] [Abstract][Full Text] [Related]
14. Higher dietary protein intake preserves lean body mass, lowers liver lipid deposition, and maintains metabolic control in participants with long-chain fatty acid oxidation disorders.
Gillingham MB; Elizondo G; Behrend A; Matern D; Schoeller DA; Harding CO; Purnell JQ
J Inherit Metab Dis; 2019 Sep; 42(5):857-869. PubMed ID: 31295363
[TBL] [Abstract][Full Text] [Related]
15. Long-chain fatty acid oxidation disorders and current management strategies.
Vockley J
Am J Manag Care; 2020 Aug; 26(7 Suppl):S147-S154. PubMed ID: 32840329
[TBL] [Abstract][Full Text] [Related]
16. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
[TBL] [Abstract][Full Text] [Related]
17. Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient.
Galron D; Birk OS; Kazanovitz A; Moses SW; Hershkovitz E
J Inherit Metab Dis; 2004; 27(2):267-73. PubMed ID: 15159657
[TBL] [Abstract][Full Text] [Related]
18. Carnitine-Acylcarnitine Translocase Deficiency Masked by Extreme Prematurity.
Lund KC; Scottoline B; Jordan BK
J Pediatr Genet; 2023 Jun; 12(2):179-183. PubMed ID: 37090833
[TBL] [Abstract][Full Text] [Related]
19. Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: Final results of an open-label, long-term extension study.
Vockley J; Burton BK; Berry G; Longo N; Phillips J; Sanchez-Valle A; Chapman KA; Tanpaiboon P; Grunewald S; Murphy E; Lu X; Rahman S; Ray K; Reineking B; Pisani L; Ramirez AN
J Inherit Metab Dis; 2023 Sep; 46(5):943-955. PubMed ID: 37276053
[TBL] [Abstract][Full Text] [Related]
20. Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation.
Iacobazzi V; Pasquali M; Singh R; Matern D; Rinaldo P; Amat di San Filippo C; Palmieri F; Longo N
Am J Med Genet A; 2004 Apr; 126A(2):150-5. PubMed ID: 15057979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
